KOREAN MISTLETOE LECTIN ENHANCING THE ANTI-TUMOUR ACTION OF INTERFERON-GAMMA, AND ANTI-CANCER COMPOSITION COMPRISING INTERFERON-GAMMA AND THE LECTIN

摘要

The present invention is interferon-gamma and Korean mistletoe lectin (Korean mistletoe lectin; KML) to relates to a composition for an anti-cancer agent for the active ingredient, and more particularly interferon-cancer action of gamma-enhancing agent of Korean mistletoe lectin (Korean mistletoe lectin; KML ) and the anti-cancer action enhancing agent and interferon-it relates to a composition for an anticancer agent comprising a gamma as an effective ingredient.; The Korean mistletoe lectin is interferon commonly used such as the treatment of cancer-gamma formulation is contained in no side effects even with low capacity effectively interferon to raise the anti-cancer effect by gamma, interferon-gamma in a small amount of 1/100 of the single dose interferon-a combined preparation by the addition of a small amount of Korean mistletoe lectin to gamma interferon, and can also mitigate many side effects due to the gamma dose, interferon-excess of the interferon gamma is no greater antitumor effect than the single administration of a cancer caused by gamma improve the therapeutic effect and the amount of interferon-gamma due to administration may reduce significantly ease the burden of medical patients.